ELA-32(human) structure
|
Common Name | ELA-32(human) | ||
|---|---|---|---|---|
| CAS Number | 1680205-79-1 | Molecular Weight | 3967.82 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C170H289N63O39S4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ELA-32(human)ELA-32(human) is a potent, high affinity apelin receptor agonist (IC50=0.27 nM; Kd=0.51 nM). ELA-32(human) exhibits no binding GPR15 and GPR25. ELA-32(human) activates the PI3K/AKT pathway and promotes self-renewal of hESCs via cell-cycle progression and protein translation. ELA-32(human) also potentiates the TGFβ pathway, priming hESCs toward the endoderm lineage. ELA-32(human) stimulates angiogenesis in HUVEC cells. |
| Name | ELA-32(human) |
|---|
| Description | ELA-32(human) is a potent, high affinity apelin receptor agonist (IC50=0.27 nM; Kd=0.51 nM). ELA-32(human) exhibits no binding GPR15 and GPR25. ELA-32(human) activates the PI3K/AKT pathway and promotes self-renewal of hESCs via cell-cycle progression and protein translation. ELA-32(human) also potentiates the TGFβ pathway, priming hESCs toward the endoderm lineage. ELA-32(human) stimulates angiogenesis in HUVEC cells. |
|---|---|
| Related Catalog |
| Molecular Formula | C170H289N63O39S4 |
|---|---|
| Molecular Weight | 3967.82 |
| InChIKey | QSDOQAYDPQAWEK-PXWSXZDTSA-N |
| SMILES | CSCCC(NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C1CCCN1C(=O)C(CCCNC(=N)N)NC(=O)C(N)CCC(N)=O)C(C)C)C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CC(N)=O)C(=O)NC1CSSCC(C(=O)NC(CCSC)C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)NC(Cc2cnc[nH]2)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(=O)N2CCCC2C(=O)NC(Cc2ccccc2)C(=O)N2CCCC2C(=O)O)C(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC1=O |